Medicine and Dentistry
Disease
98%
Malignant Neoplasm
68%
Neoplasm
62%
Infection
49%
Pediatrics
46%
Transplantation
35%
COVID-19
33%
Pancreas Cancer
30%
Surgery
30%
Oncology
28%
Health Care Cost
28%
Overall Survival
28%
Human Immunodeficiency Virus
26%
Metastatic Carcinoma
26%
Injury
26%
Clinical Trial
25%
Rheumatoid Arthritis
25%
Non-Hodgkin Lymphoma
24%
Diagnosis
24%
Surgeon
24%
Systematic Review
23%
Symptom
22%
Radiation Therapy
22%
Chronic Obstructive Pulmonary Disease
20%
Breast Cancer
19%
Drug Therapy
18%
Cancer
18%
Prevalence
18%
Diabetes
18%
Biological Marker
18%
Clinician
17%
Pancreas Adenocarcinoma
17%
Liver Transplantation
16%
Odds Ratio
16%
Primary Health Care
16%
Meta-Analysis
16%
Diffuse Large B-Cell Lymphoma
16%
Health Care
16%
Quality of Life
15%
Public Health
15%
Heart Failure
15%
Cancer Cell
15%
In Vitro
14%
Recurrent Disease
13%
Prostate Cancer
12%
T Cell
12%
Antibiotics
12%
Adverse Event
12%
Drug Megadose
12%
Hodgkin's Lymphoma
12%
Severe Acute Respiratory Syndrome Coronavirus 2
11%
Biopsy
11%
Randomized Controlled Trial
11%
Medicine
11%
Logistic Regression Analysis
11%
Epithelial Cell
10%
Quality Improvement
10%
Magnetic Resonance Imaging
10%
Hazard Ratio
10%
Hematopoietic Stem Cell
10%
Adolescent
10%
Apoplexy
10%
Lung Cancer
10%
Virus Infection
10%
Tumor Cell
10%
Cohort Analysis
9%
Diabetes Mellitus
9%
Colorectal Cancer
9%
Combination Therapy
9%
Non Small Cell Lung Cancer
9%
Peripheral T-Cell Lymphoma
9%
Pediatrics Patient
9%
Cancer Therapy
9%
Awareness
9%
B Cell
9%
Mantle Cell Lymphoma
9%
Placebo
9%
Immunotherapy
9%
Stem Cell
9%
Cardiovascular Disease
8%
Gene Expression
8%
Acute Myeloid Leukemia
8%
Patient Care
8%
Carcinogenesis
8%
Body Mass Index
8%
Cardiovascular System
8%
Computer Assisted Tomography
8%
Pathogen
8%
Randomized Clinical Trial
8%
Myocardial Infarction
8%
Short Bowel Syndrome
8%
Physical Activity
8%
Multiple Myeloma
8%
Patient Referral
8%
Targeted Therapy
8%
Emergency Department
8%
Echocardiography
8%
Cell Transplantation
8%
Survival Rate
8%
Maturity Onset Diabetes of the Young
7%
Pharmacology, Toxicology and Pharmaceutical Science
Disease
100%
Malignant Neoplasm
82%
Mouse
69%
Neoplasm
55%
Infection
46%
HIV
45%
Rheumatoid Arthritis
32%
Pancreas Cancer
31%
Clinical Trial
28%
Ethanol
26%
Heart Failure
24%
Chemotherapy
24%
Inflammation
23%
Pharmacokinetics
22%
Chronic Obstructive Lung Disease
22%
Biological Marker
21%
Receptor
20%
Prostate Cancer
20%
Adverse Event
18%
Breast Cancer
18%
Placebo
18%
Combination Therapy
17%
Mouse Model
16%
Carcinogenesis
16%
Overall Survival
16%
Injury
16%
Nanoparticle
15%
Pancreas Adenocarcinoma
14%
Nonhodgkin Lymphoma
14%
Symptom
14%
Cytokine
14%
Prevalence
13%
SARS Coronavirus
13%
Heart Infarction
12%
Diabetes Mellitus
12%
Coronavirinae
11%
Cardiovascular Disease
11%
Antiinfective Agent
11%
Infectious Agent
10%
Antibiotic Agent
10%
Cytotoxicity
10%
Antibiotics
10%
Cohort Study
10%
Lung Cancer
10%
Cancer Growth
10%
microRNA
10%
Randomized Controlled Trial
10%
Metastasis
9%
Carcinogenicity
9%
Methotrexate
9%
Epileptic Absence
8%
Colorectal Cancer
8%
Antioxidant
8%
Tumor Growth
8%
Cholinesterase
8%
Epidermal Growth Factor Receptor
8%
Tumor Necrosis Factor
8%
Vitamin D
8%
Cigarette Smoke
8%
Liver Disease
8%
Reactive Oxygen Metabolite
8%
Remission
8%
Comorbidity
8%
Carcinogen
8%
Doxorubicin
8%
Liver Injury
8%
Transforming Growth Factor
8%
Small Interfering RNA
8%
Copolymer
7%
Prodrug
7%
Fibrosis
7%
Amino Acid
7%
Colon Cancer
7%
Recurrent Disease
7%
Human Immunodeficiency Virus Infection
7%
Pharmacotherapy
7%
Parkinson's Disease
7%
Angiotensin II
7%
Coronary Artery Disease
7%
Quinone Derivative
6%
Knockout Mouse
6%
Biodistribution
6%
Side Effect
6%
Non Insulin Dependent Diabetes Mellitus
6%
Micelle
6%
Drug Resistance
6%
Immunotherapy
6%
Dexamethasone
6%
Base
6%
Virus Infection
6%
Cyclophosphamide
6%
Sodium Chloride
6%
Randomized Clinical Trial
6%
Pandemic
6%
Chemokine
6%
Disease Exacerbation
6%
Gemcitabine
6%
Staphylococcus Aureus
6%
Syndrome
6%
Disease Activity
6%
Keyphrases
Rheumatoid Arthritis
13%
United States
13%
Human Immunodeficiency Virus Type 1 (HIV-1)
13%
NCCN Guidelines
12%
Confidence Interval
11%
Tumor
11%
Non-Hodgkin Lymphoma
11%
Pancreatic Cancer
10%
Nebraska
10%
Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT)
10%
Heart Failure
9%
COVID-19
9%
Lymphoma
9%
Overall Survival
9%
Clinical Trials
9%
Ethanol
8%
Oncology
8%
Chemotherapy
8%
Liver
8%
Chronic Obstructive Pulmonary Disease
8%
Clinical Practice Guidelines
7%
Diffuse Large B-cell Lymphoma (DLBCL)
7%
Alcohol
7%
Risk Factors
7%
Inflammation
7%
In Cancer
7%
T Cells
7%
AIDS/HIV
6%
Oxidative Stress
6%
Transplantation
6%
Older Adults
6%
Transforming Growth Factor-β
6%
Meta-analysis
6%
Cell Proliferation
6%
Chronic Heart Failure
6%
Growth Factors
5%
Type 1 Diabetes Mellitus (T1DM)
5%
Pancreatic Ductal Adenocarcinoma
5%
Phosphorylation
5%
Macrophages
5%
Breast Cancer
5%
Apoptosis
5%
Peripheral T-cell Lymphoma
5%
Blood-brain Barrier
5%